medic
hypothes
journal
homepag
wwwelseviercomlocatemehi
till
moment
approv
antivir
treatment
saikosaponin
saikosaponin
b
saikosaponin
major
triterpenoid
saponin
deriv
bupleurum
falcatum
l
umbellifera
valuabl
pharmacolog
activ
activ
compon
exbibit
sever
immunomodulatori
antiinflammatori
antibacteri
antivir
anticanc
effect
propos
saikosaponin
might
hold
promis
treatment
base
follow
rational
saikosaponin
exhibit
immunomodulatori
antiinflammatori
activ
saikosaponin
dosedepend
inhibit
product
sever
inflammatori
mediat
ro
tnfa
ino
interleukin
respons
cytokin
storm
sever
patient
saikosaponin
could
exhibit
antiprolif
effect
activ
tlymphocyt
part
via
suppress
nucleotidebind
oligomer
domain
nfat
mapk
signal
play
role
sever
mortal
viru
reduc
lung
immunopatholog
saikosaponin
b
demonstr
invitro
antivir
activ
inhibit
viral
attach
cell
dosedepend
manner
block
viral
penetr
cell
interf
earli
stage
viral
replic
viru
absorpt
penetr
saikosaponin
inhibit
autophag
activ
enteroviru
molecular
dock
studi
demonstr
saikosaponin
high
affin
bind
target
receptor
ace
ii
receptor
conclus
believ
saikosaponin
candid
treatment
owe
antiinflammatori
immunomodulatori
antivir
activ
recommend
futur
welldesign
random
control
trial
evalu
safeti
efficaci
saikosaponin
patient
